Background: The clinical spectrum of neurosyphilis (NS) has changed over time. Objective: To describe the clinical spectrum and characteristics of NS in HIV-negative patients. Methods: A retrospective chart review was performed for 149 in patients with NS. Result: All patients were >25 years old, including 16.8% asymptomatic for NS, 15.4% with syphilitic meningitis, 24.2% with meningovascular NS, 38.9% with general paresis, 4.0% with tabes dorsalis and 0.7% with gummatous NS. The original misdiagnosis rate was 84.6%. All 149 patients had positive serum Treponema pallidum particle agglutination (TPPA) and rapid plasma reagin (RPR). The overall positive rates of cerebrospinal fluid RPR (CSF-RPR) and CSF-TPPA were 57.0 and 89.9%, respectively. CSF pleocytosis and elevated CSF protein were found in 40.3% of patients. Nonspecific abnormal brain magnetic resonance imaging and electroencephalography findings were present in 60.4 and 54.8% of NS patients, respectively. Conclusions: NS has various clinical manifestations, laboratory findings and magnetic resonance imaging and electroencephalography findings, but all studies lack specificity. Every patient with neurological or psychiatric symptoms that are without unambiguous causes should have blood tests for syphilis. When serology proves positive, patients should undergo CSF examination.

1.
Shah BB, Lang AE: Acquired neurosyphilis presenting as movement disorders. Mov Disord 2012;27:690-695.
2.
Conde-Sendin MA, Amela-Peris R, Aladro-Benito Y, Maroto AAM: Current clinical spectrum of neurosyphilis in immunocompetent patients. Eur Neurol 2004;52:29-35.
3.
Danielsen AG, Weismann K, Jorgensen B, Heidenheim M, Fugleholm AM: Incidence, clinical presentation and treatment of neurosyphilis in Denmark 1980-1997. Acta Derm Venereol 2004;84:459-462.
4.
Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG, Lin LR, Yang TC: Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. J Neurol Sci 2012;317:35-39.
5.
Kofman O: The changing pattern of neurosyphilis. Can Med Assoc J 1956;74:807-812.
6.
Joffe R, Black MM, Floyd M: Changing clinical picture of neurosyphilis: report of seven unusual cases. Br Med J 1968;1:211-212.
7.
Hook EW 3rd, Marra CM: Acquired syphilis in adults. N Engl J Med 1992;326:1060-1069.
8.
Schoutens C, Boute V, Govaerts D, De Dobbeleer G: Late cutaneous syphilis and neurosyphilis. Dermatology 1996;192:403-405.
9.
Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G: Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis 1998;177:931-940.
10.
Johns DR, Tierney M, Felsenstein D: Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987;316:1569-1572.
11.
Mitsonis CH, Kararizou E, Dimopoulos N, Triantafyllou N, Kapaki E, Mitropoulos P, Sfagos K, Vassilopoulos D: Incidence and clinical presentation of neurosyphilis: a retrospective study of 81 cases. Int J Neurosci 2008;118:1251-1257.
12.
Centers for Disease Control and Prevention: 1998 guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep 1998;47:1-111.
13.
Lin LR, Fu ZG, Dan B, Jing GJ, Tong ML, Chen DT, Yu Y, Zhang CG, Yang TC, Zhang ZY: Development of a colloidal gold-immunochromatography assay to detect immunoglobulin G antibodies to Treponema pallidum with TPN17 and TPN47. Diagn Microbiol Infect Dis 2010;68:193-200.
14.
Lin LR, Tong ML, Fu ZG, Dan B, Zheng WH, Zhang CG, Yang TC, Zhang ZY: Evaluation of a colloidal gold immunochromatography assay in the detection of Treponema pallidum specific IgM antibody in syphilis serofast reaction patients: a serologic marker for the relapse and infection of syphilis. Diagn Microbiol Infect Dis 2011;70:10-16.
15.
Roberts MC, Emsley RA: Cognitive change after treatment for neurosyphilis. Correlation with CSF laboratory measures. Gen Hosp Psychiatry 1995;17:305-309.
16.
Lin LR, Zheng WH, Tong ML, Fu ZG, Liu GL, Fu JG, Zhang DW, Yang TC, Liu LL: Further evaluation of the characteristics of Treponema pallidum-specific IgM antibody in syphilis serofast reaction patients. Diagn Microbiol Infect Dis 2011;71:201-207.
17.
Burke JM, Schaberg DR: Neurosyphilis in the antibiotic era. Neurology 1985;35:1368-1371.
18.
Asdaghi N, Muayqil T, Scozzafava J, Jassal R, Saqqur M, Jeerakathil TJ: The re-emergence in Canada of meningovascular syphilis: 2 patients with headache and stroke. CMAJ 2007;176:1699-1700.
19.
Merritt HH, Adams RD, Solomon HC: Neurosyphilis. New York, Oxford University Press, 1916.
20.
SAK W: Neurology. London, Butterworth, 1940.
21.
Musher DM: Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 1991;163:1201-1206.
22.
Hooshmand H, Escobar MR, Kopf SW: Neurosyphilis. A study of 241 patients. JAMA 1972;219:726-729.
23.
Lukehart SA, Hook EW 3rd, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH: Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med 1988;109:855-862.
24.
Luxon L, Lees AJ, Greenwood RJ: Neurosyphilis today. Lancet 1979;1:90-93.
25.
Joyce-Clarke N, Molteno AC: Modified neurosyphilis in the Cape Peninsula. S Afr Med J 1978;53:10-14.
26.
Ghanem KG: Review: Neurosyphilis: a historical perspective and review. CNS Neurosci Ther 2010;16:e157-e168.
27.
Lynn WA, Lightman S: Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004;4:456-466.
28.
Timmermans M, Carr J: Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 2004;75:1727-1730.
29.
Kararizou E, Mitsonis C, Dimopoulos N, Gkiatas K, Markou I, Kalfakis N: Psychosis or simply a new manifestation of neurosyphilis? J Int Med Res 2006;34:335-337.
30.
Roberts MC, Emsley RA: Psychiatric manifestations of neurosyphilis. S Afr Med J 1992;82:335-337.
31.
Sirota P, Eviatar J, Spivak B: Neurosyphilis presenting as psychiatric disorders. Br J Psychiatry 1989;155:559-561.
32.
Mao SY, Liu ZR: Neurosyphilis manifesting as lightning pain. Eur J Dermatol 2009;19:504-506.
33.
Hotson JR: Modern neurosyphilis: a partially treated chronic meningitis. West J Med 1981;135:191-200.
34.
Shah BB, Lang AE: A case of neurosyphilis presenting with myoclonus, cerebellar ataxia, and speech disturbance. Mov Disord 2012;27:794.
35.
Chan DJ: Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 2005;3:95-98.
36.
French P, Gomberg M, Janier M, Schmidt B, van Voorst Vader P, Young H; IUST: IUSTI: 2008 European Guidelines on the Management of Syphilis. Int J STD AIDS 2009;20:300-309.
37.
Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC): Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.
38.
Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, Stoner BP, Augenbraun M, Barker DE, Corbett JJ: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004;189:369-376.
39.
Libois A, De Wit S, Poll B, Garcia F, Florence E, Del Rio A, Sanchez P, Negredo E, Vandenbruaene M, Gatell JM, Clumeck N: HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007;34:141-144.
40.
Garcia P, Grassi B, Fich F, Salvo A, Araya L, Abarzua F, Soto J, Poggi H, Lagos M, Vasquez P, Leon EP, Perez C, Wozniak A: Laboratory diagnosis of Treponema pallidum infection in patients with early syphilis and neurosyphilis through a PCR-based test. Rev Chilena Infectol 2011;28:310-315.
41.
Paraskevas GP, Kapaki E, Kararizou E, Mitsonis C, Sfagos C, Vassilopoulos D: Cerebrospinal fluid tau protein is increased in neurosyphilis: a discrimination from syphilis without nervous system involvement? Sex Transm Dis 2007;34:220-223.
42.
Booth J, Rodger A, Singh J, Alexander S, Hopkins S: Syphilitic panuveitis with retinal necrosis in an HIV positive man confirmed by Treponema pallidum PCR. J Infect 2009;59:373-375.
43.
Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA: CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 2010;37:283-287.
44.
Berbel-Garcia A, Porta-Etessam J, Martinez-Salio A, Millan-Juncos J, Perez-Martinez DA, Saiz-Diaz RA, Toledo-Heras M: Magnetic resonance image-reversible findings in a patient with general paresis. Sex Transm Dis 2004;31:350-352.
45.
Fadil H, Gonzalez-Toledo E, Kelley BJ, Kelley RE: Neuroimaging findings in neurosyphilis. J Neuroimaging 2006;16:286-289.
46.
Marano E, Briganti F, Tortora F, Elefante A, De Rosa A, Maiuri F, Filla A: Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 2004;75:833.
47.
Kearney H, Mallon P, Kavanagh E, Lawler L, Kelly P, O'Rourke K: Amnestic syndrome due to meningovascular neurosyphilis. J Neurol 2010;257:669-671.
48.
Kodama K, Okada S, Komatsu N, Yamanouchi N, Noda S, Kumakiri C, Sato T: Relationship between MRI findings and prognosis for patients with general paresis. J Neuropsychiatry Clin Neurosci 2000;12:246-250.
49.
Sinha S, Harish T, Taly AB, Murthy P, Nagarathna S, Chandramuki A: Symptomatic seizures in neurosyphilis: an experience from a university hospital in south India. Seizure 2008;17:711-716.
50.
Yu YX, Wei MQ, Huang YG, Jiang W, Liu XD, Xia F, Li DSA, Zhao G: Clinical presentation and imaging of general paresis due to neurosyphilis in patients negative for human immunodeficiency virus. J Clin Neurosci 2010;17:308-310.
51.
Tantalo LC, Lukehart SA, Marra CM: Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model. J Infect Dis 2005;191:75-80.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.